Kymera Therapeutics, Inc. Quarterly Common Stock, Shares, Outstanding from Q4 2019 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Kymera Therapeutics, Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2019 to Q3 2024.
  • Kymera Therapeutics, Inc. Common Stock, Shares, Outstanding for the quarter ending September 30, 2024 was 64.7M shares, a 16.8% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 64.7M +9.3M +16.8% Sep 30, 2024 10-Q 2024-10-31
Q2 2024 61.6M +6.18M +11.2% Jun 30, 2024 10-Q 2024-08-07
Q1 2024 61.4M +6.08M +11% Mar 31, 2024 10-Q 2024-05-02
Q4 2023 55.4M +351K +0.64% Dec 31, 2023 10-Q 2024-10-31
Q3 2023 55.5M +699K +1.28% Sep 30, 2023 10-Q 2023-11-02
Q2 2023 55.4M +3.54M +6.83% Jun 30, 2023 10-Q 2023-08-03
Q1 2023 55.3M +3.58M +6.93% Mar 31, 2023 10-Q 2023-05-04
Q4 2022 55M +3.5M +6.8% Dec 31, 2022 10-Q 2023-11-02
Q3 2022 54.8M +3.49M +6.82% Sep 30, 2022 10-Q 2022-11-03
Q2 2022 51.8M +6.52M +14.4% Jun 30, 2022 10-Q 2022-08-09
Q1 2022 51.7M +6.81M +15.2% Mar 31, 2022 10-Q 2022-05-03
Q4 2021 51.5M +7.05M +15.9% Dec 31, 2021 10-K 2023-02-23
Q3 2021 51.3M +6.81M +15.3% Sep 30, 2021 10-Q 2021-11-10
Q2 2021 45.3M Jun 30, 2021 10-Q 2021-08-06
Q1 2021 44.9M Mar 31, 2021 10-Q 2021-05-06
Q4 2020 44.5M +42.6M +2205% Dec 31, 2020 10-K 2022-02-24
Q3 2020 44.4M Sep 30, 2020 10-Q 2020-11-05
Q4 2019 1.93M Dec 31, 2019 10-K 2021-03-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.